143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Form of B12 deficiency in cerebral spinal fluid found to negatively affect the central nervous system

Form of B12 deficiency in cerebral spinal fluid found to negatively affect the central nervous system

by Bob Yirka , Medical XpressA patient with an unsual MRI and neurologic deficits eluded typical diagnostic tests.Credit: John PluvinageA large team of doctors and medical researchers with diver

Form of B12 deficiency in cerebral spinal fluid found to negatively affect the central nervous system

by Bob Yirka , Medical XpressA patient with an unsual MRI and neurologic deficits eluded typical diagnostic tests.Credit: John PluvinageA large team of doctors and medical researchers with diver
Cortexyme publishes data on P. gingivalis ability to infect neurons

Cortexyme publishes data on P. gingivalis ability to infect neurons

by IOS PressP. gingivalisbacteria (arrows), after invading a neuron, causes damage to the cellular infrastructure and synapses. Credit: Cortexyme, Inc.Cortexyme, Inc., a clinical stage biop

Cortexyme publishes data on P. gingivalis ability to infect neurons

by IOS PressP. gingivalisbacteria (arrows), after invading a neuron, causes damage to the cellular infrastructure and synapses. Credit: Cortexyme, Inc.Cortexyme, Inc., a clinical stage biop
Lightweight, head-mounted microscope unveils brain oxygenation in freely moving mice

Lightweight, head-mounted microscope unveils brain oxygenation in freely moving mice

by TranSpreadPhotoacoustic fiberscope for cerebral imaging in the freely moving-state. Credit:Light: Science & Applications(2024). DOI: 10.1038/s41377-023-01348-3The brain consumes app

Lightweight, head-mounted microscope unveils brain oxygenation in freely moving mice

by TranSpreadPhotoacoustic fiberscope for cerebral imaging in the freely moving-state. Credit:Light: Science & Applications(2024). DOI: 10.1038/s41377-023-01348-3The brain consumes app
First 'gene silencing' drug for Alzheimer's disease shows promise

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T
Decoding the genetics that drive disease

Decoding the genetics that drive disease

by University of South AustraliaSome human genes traditionally labeled as 'bad' are not always what they seem. Credit: Gerd Altmann from PixabayFrom Alzheimer's to obesity, life can c

Decoding the genetics that drive disease

by University of South AustraliaSome human genes traditionally labeled as 'bad' are not always what they seem. Credit: Gerd Altmann from PixabayFrom Alzheimer's to obesity, life can c
Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

by Atrium Health Wake Forest BaptistSenescent neurons are represented by areas of blue, red and white. Senescent cells are old, sick cells that cannot properly repair themselves and don't die

Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

by Atrium Health Wake Forest BaptistSenescent neurons are represented by areas of blue, red and white. Senescent cells are old, sick cells that cannot properly repair themselves and don't die
Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement
Study discovers possible tool to diagnose common contributor to vascular dementia

Study discovers possible tool to diagnose common contributor to vascular dementia

by Keck School of Medicine of USCOptical coherence tomography angiography (OCTA) images representative of high (top row), and low (bottom row) OCTA perfusion measures, and their corresponding FW

Study discovers possible tool to diagnose common contributor to vascular dementia

by Keck School of Medicine of USCOptical coherence tomography angiography (OCTA) images representative of high (top row), and low (bottom row) OCTA perfusion measures, and their corresponding FW
Veterans experiencing housing instability may face an elevated risk of developing dementia

Veterans experiencing housing instability may face an elevated risk of developing dementia

by WileyCredit: Pixabay/CC0 Public DomainIn a recent studypublishedinJournal of the American Geriatrics Society, Veterans with housing instability were 53% more likely to receiv

Veterans experiencing housing instability may face an elevated risk of developing dementia

by WileyCredit: Pixabay/CC0 Public DomainIn a recent studypublishedinJournal of the American Geriatrics Society, Veterans with housing instability were 53% more likely to receiv
Super-resolution microscopy sheds light on how dementia protein becomes dysfunctional

Super-resolution microscopy sheds light on how dementia protein becomes dysfunctional

by University of QueenslandThe signalling protein Fyn moving and forming clusters in living brain cells - viewed using super-resolution microscopy. Credit: Meunier Lab, University of QueenslandUn

Super-resolution microscopy sheds light on how dementia protein becomes dysfunctional

by University of QueenslandThe signalling protein Fyn moving and forming clusters in living brain cells - viewed using super-resolution microscopy. Credit: Meunier Lab, University of QueenslandUn
Diagnosis of Alzheimer's and related dementias reduces social activity

Diagnosis of Alzheimer's and related dementias reduces social activity

by Rutgers UniversityCredit: Pixabay/CC0 Public DomainDespite the belief that early diagnosis of Alzheimer's disease and other dementias is crucial, a new Rutgers study found that the diagnos

Diagnosis of Alzheimer's and related dementias reduces social activity

by Rutgers UniversityCredit: Pixabay/CC0 Public DomainDespite the belief that early diagnosis of Alzheimer's disease and other dementias is crucial, a new Rutgers study found that the diagnos
Dementia study reveals how toxic proteins spread through brain

Dementia study reveals how toxic proteins spread through brain

by University of EdinburghGraphical Abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.04.020Fresh insights into the spread of damaging proteins that build up in the brains of

Dementia study reveals how toxic proteins spread through brain

by University of EdinburghGraphical Abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.04.020Fresh insights into the spread of damaging proteins that build up in the brains of